The Apolipoprotein E (APOE) e4 allele is the best-established genetic risk factor for sporadic Alzheimer's disease, and is also associated with structural gray matter and functional brain changes in healthy young, middle-aged and elderly subjects. Because APOE is implicated in brain mechanisms associated with white matter (WM) development and repair, we investigated the potential role played by the APOE polymorphism on WM structure in healthy younger (aged 20-35 years) and older (aged 50-78 years) adults using diffusion tensor imaging. General reduction of fractional anisotropy and increase in mean diffusivity values was found in carriers of the APOE e4 allele relative to non-carriers. No significant interactions between genotype and age were observed, suggesting that differences in WM structure between APOE e4-carriers and non-carriers do not undergo significant differential changes with age. This result was not explained by differences in brain morphology or cognitive measures. The APOE e4 allele modulates brain WM structure before any clinical or neurophysiological expression of impending disease.
Introduction
Apolipoprotein E (apoE, protein; APOE, gene) is a very-low-density lipoprotein that has a key role in coordinating the mobilization and redistribution of cholesterol, phospholipids and fatty acids. 1 In the central nervous system, apoE is implicated in mechanisms, such as neuronal development, brain plasticity and repair functions. 2, 3 The human APOE gene has three allelic variants (e2, e3 and e4). The e4 allele is associated with higher risk of developing both earlyonset 4 and late-onset 5 Alzheimer's disease (AD), poor outcome from traumatic brain injury 6 and age-related cognitive impairment. 7 Neuroimaging studies have shown that the APOE e4 allele is associated with modification of brain function and gray matter (GM) structure, both in AD patients [8] [9] [10] and in healthy subjects. [11] [12] [13] [14] [15] GM volume reduction in AD patients carrying the e4 allele relative to non-carriers has been found mainly in the hippocampus and entorhinal cortex. 8, 10, 16, 17 Similarly, reductions in medial temporal lobe (MTL) volumes have been reported among healthy middle-aged/elderly, [18] [19] [20] [21] and adolescent 22 APOE e4-carriers, although not all studies replicate this finding. [23] [24] [25] Positron emission tomography studies have consistently shown resting glucose metabolism reduction in healthy young and middle-aged APOE e4-carriers in brain regions known to be affected by AD pathology, such as the parietal, temporal and prefrontal cortices. 12, 13 Task-based functional magnetic resonance imaging (fMRI) studies have been less consistent, showing increased, 11, 14, 15 decreased 26, 27 or even no difference 28 in task-related blood oxygen level dependent (BOLD) signal between healthy APOE e4-carriers and non-carriers. Methodological differences may explain inconsistencies in the studies.
Because of the link between APOE and AD, to date structural imaging studies have largely concentrated on GM changes, especially in the entorhinal cortex and hippocampal regions, which are the first structures to show AD pathology. 29 Very few studies have investigated the potential effects of the APOE genotype on white matter (WM) structure. This is surprising considering that the major role of apoE in the brain is the transport of lipid components that contribute to building up the myelin sheath. [30] [31] [32] Moreover, AD pathology not only involves GM atrophy but also changes in WM, 33 which have been shown to correlate with disease severity. 34, 35 Diffusion tensor imaging (DTI) is an imaging technique that is increasingly used for WM analysis in vivo. DTI-derived measurements, such as fractional anisotropy (FA) and mean diffusivity (MD), have proved to be sensitive for detection of disease-related WM changes. 36 A recent meta-analysis of DTI measurements in AD and mild cognitive impairment (MCI) reported widespread increases in MD and decreases in FA with large effect sizes. 37 To date studies using DTI to investigate the effects of APOE on FA and MD have focused on specific age groups 38 or were limited to preselected regions-of-interest. 39 The aim of this study is to investigate the relationship between APOE genotype, WM structure and age in healthy individuals using an unbiased whole-brain analysis (tract-based spatial statistics (TBSS) 40 ) using DTI. This will allow us to investigate whether the e4 allele selectively modulates well-defined WM pathways or rather has a more general effect. In particular, we will test whether the APOE e4 allele alters WM integrity both in distinct groups of younger (aged 20-35 years) and older (aged 50-78 years) participants.
On the basis of the previously reported studies showing age-related WM changes in healthy subjects, [41] [42] [43] [44] we hypothesize that older subjects will have increased MD and reduced FA. As the APOE e4 allele is associated with an earlier onset of AD 4 and cognitive decline at a younger age, 7 we expect that the trajectories of WM changes with age will differ between APOE e4-carriers and non-carriers. Moreover, we will study GM volumes to investigate whether whole-brain GM or WM analyses are more sensitive to changes associated with the APOE e4 allele. On the basis of a previous study, 20 we hypothesize that GM volume will be reduced in older APOE e4-carriers. Lastly, we will compare the data between younger and older groups to study a possible interaction between age and genotype. We will test alternative hypotheses: either brain structure of APOE e4-carriers already differs from non-carriers in young adulthood or structural modifications associated with the APOE e4 allele only manifest at a certain age, perhaps preceding AD development in healthy adults.
Materials and methods

Participants
Imaging data for 73 right-handed subjects (35 males) aged 20-78 years were acquired. A total of 34 subjects aged 20-35 years comprised the 'younger' group (mean age 28.6 years ± 4.20) and 39 subjects aged 50-78 years (mean 64.9 years±7.19) comprised the 'older' group.
A priori exclusion criteria were: current or past history of neurological or psychiatric disorders, memory complaints, head injury, substance abuse (including alcohol), corticosteroid therapy and youth diabetes therapy. A posteriori (after MRI scan) exclusion criteria included presence of brain vascular insults and two or more hyperintense lesions equal or larger than 10 mm diameter, or more than eight hyperintense lesions with a diameter from 5 to 9 mm, 45 on a fluid attenuated inversion recovery image. To exclude possible confounds due to cognitive complaints older subjects underwent a pre-screening cognitive test (Addenbrooke's Cognitive Examination-revised version 46 ). Subjects were pre-screened for APOE genotype (using a cheek swab sample) and selected for the study on the basis of either having an APOE e4 allele (APOE e4-carrier) or being an e3 homozygote (noncarrier). Three APOE e4-carriers were homozygous for the e4 allele (one in the younger and two in the older group). The genotyping process was conducted at the Wellcome Trust Centre for Human Genetics in Oxford. DNA was extracted from cheek swab samples of subjects according to standard procedures to allow PCR for the characterization of APOE genotype. The study was approved by the local Ethics Committee, and written informed consent was signed by all participants. 
Image acquisition
Image analysis
Data analysis was carried out using FMRIB Software Library tools (www.fmrib. ox.ac.uk/fsl).
DTI. Raw images were pre-processed using 'Eddy Current correction', to correct for distortions due to the gradient directions applied. Fractional anisotropy (FA) and mean diffusivity (MD) maps were generated using DTIFit, part of FMRIB's Diffusion Toolbox (http://www.fmrib. ox.ac.uk/fsl/fdt), that fits a diffusion tensor model at each voxel. 47 The magnitude and direction of tissue water mobility is measured in the three dimensions 48 and the diffusion tensor is modelled as an ellipsoid with symmetry across any one of its three axes. The largest axis or eigenvalue is denoted l1 or axial diffusivity (DA). The two minor axes (l2 and l3) are usually averaged to compute radial diffusivity (DR). The average of all three eigenvalues is called MD. FA is a ratio of DA to DR, and thus provides a measure of the directionality of diffusion. In axons, net intravoxel water diffusion perpendicular to the fibres is reduced due to the myelin sheath, but unrestricted parallel to the axon. This directionality of water diffusion gives rise to a higher FA in WM, whereas less restricted diffusion, for example, in GM or cerebrospinal fluid leads to lower FA. GM and WM have similar MD values.
The FA output images were used as input for TBSS, a voxelwise approach for analysis of FA data. 40 All subjects' FA data were aligned into a common space using FMRIB's Non-linear Image Registration Tool (FNIRT). The mean FA image was generated and thinned to create a mean FA skeleton, which represents the centres of all tracts common to the group. Each subject's aligned FA data was then projected onto this skeleton and the resulting data fed into voxelwise general linear modeling crosssubject statistics. A voxel by voxel permutation nonparametric test (5000 permutations) was used to assess group-related differences using threshold-free cluster enhancement, which avoids using an arbitrary threshold for the initial cluster-formation. 40 All results are shown at P < 0.05 corrected for multiple comparisons across space. In addition to FA data, MD, DA and DR were also compared using TBSS in an analogous fashion. Separate analyses were performed for the younger and older group, and then data from both groups were pooled together. GM volume, WM volume and cognitive scores were added to the TBSS analysis as covariates of no interest.
Structural MRI. A voxel-based morphometry approach was used to study brain morphology and to relate it to the APOE polymorphism. Total brain volume, GM, WM and cerebrospinal fluid measurements were calculated using FMRIB's automated segmentation tool. 49 Whole-brain analysis was carried out with FMRIB Software Library-voxel-based morphometry, 50 using default settings. In brief, brain extraction and tissue-type segmentation were performed and the resulting GM or WM partial volume images were aligned to standard space using FMRIB's Linear Image Registration Tool (FLIRT) and then nonlinear (FNIRT) registration tools. The resulting images were averaged, modulated and smoothed with an isotropic Gaussian kernel of 3 mm (B7 mm full width at half maximum (FWHM)) to create a study-specific template. Finally, voxelwise general linear modeling was applied using permutation nonparametric testing (5000 permutations) and P < 0.05 correcting for multiple comparisons across space. GM volume and total brain volume were used as covariates of no interest in the voxelbased morphometry analysis.
Regions-of-interest analysis of hippocampal volume. Individual hippocampal measures were obtained using FMRIB'S Integrated Registration and Segmentation Tool (FIRST), an automatic subcortical segmentation program. 51 Boundary correction was used for the classification of the boundary voxels. Regions-of-interest were visually inspected in the coronal plane to ensure accuracy.
WM lesions. Measurement of WM lesions in the older group was manually performed on fluid attenuated inversion recovery images by a trained neuroscientist (VH) blind to the genotypic profile using the Jim 4.0 software (Xinapse Medical Systems, Thorpe Waterville, UK). All axial slices of each subject were investigated for WM hyperintensities and periventricular WM lesions. After marking all hyperintensities and periventricular lesions as regions-of-interest, total volume was calculated for each subject.
Statistics. Statistical analyses of non-imaging variables were carried out using SPSS software (SPSS, Chicago, USA). T-tests comparison were used for continuous variables (sociodemographic, cognitive performance and brain volumes). Exact Fisher's continuity correction was used for categorical variables (gender and family history of dementia). An alpha of P < 0.05 was considered significant.
Results
Participants
A total of 73 subjects completed the MRI protocol. Two of the older subjects (one APOE e4-carrier and one non-carrier) were excluded because they showed an abnormally high volume of WM lesions (more than three s.d. from each group mean), leaving a total of 71 subjects (Table 1) . There was no effect of genotype on WM lesion volume (F 1,34 = 2.40, P = 0.13). Within the younger and older group, APOE e4-carriers and noncarriers did not differ for age, sex, years of education, number of individuals with a family history of dementia and Addenbrooke's Cognitive Examinationrevised version results. Similarly, memory performance and reaction times in an encoding memory task as described in Filippini et al. 52 were not different between APOE e4-carriers and non-carriers (Table 1) .
DTI
In the younger group whole-brain WM analysis with TBSS revealed decreased FA values in APOE e4-carriers relative to non-carriers in widespread areas, including the cingulum, corona radiata, corpus callosum, external capsule, internal capsule and superior longitudinal fasciculus (Figure 1a ). There were no regions in which FA values were higher in APOE e4-carriers relative to non-carriers. The decreased FA in APOE e4-carriers was not associated with significant differences in MD, DA or DR.
In the older group, whole-brain analysis with TBSS showed increased MD in APOE e4-carriers relative to non-carriers in widespread areas, including the cingulum, corona radiata, corpus callosum, external capsule, internal capsule and superior longitudinal fasciculus (Figure 1b) , but there were no significant differences in FA, DR or DA. There were no regions in which MD values were lower in APOE e4-carriers relative to non-carriers.
TBSS analysis with the data from both age groups combined was performed to study a possible interaction between AGE (younger or older) and GENOTYPE (APOE e4-carrier or non-carrier) factors. No significant interaction between the two factors was detected Effect of APOE e4 allele on brain white matter integrity V Heise et al for FA or MD. However, a main effect of GENOTYPE was found for FA values in areas, including the cingulum, corona radiata, corpus callosum, external capsule, internal capsule and superior longitudinal fasciculus (Figure 1c ). In addition, DR was significantly higher in APOE e4-carriers compared with non-carriers (Figure 1d ), but there were no significant effects on MD or DA.
As we expected, a widespread main effect of AGE was observed for FA. FA was significantly increased in the younger compared with the older group in WM tracts, including the cingulum, corona radiata, corpus callosum, external capsule, internal capsule and superior longitudinal fasciculus (Figure 2a) . This was associated with significantly increased DA and DR in the older group (Figures 2c and d) . The same structures showed significantly increased MD values in the older group (Figure 2b ). There were no regions in which FA values were higher or MD, DA or DR values were lower in the older group compared with the younger group.
Structural MRI
No differences between APOE e4-carriers and noncarriers in both age groups were found for total brain volume, GM volume, WM volume, cerebrospinal fluid and hippocampal volumes (Table 1) . Moreover, no differences between APOE e4-carriers and non-carriers were observed in GM or WM using a whole-brain Voxel-Based-Morphometry approach.
Discussion
We investigated the effect of the APOE genotype on WM structure in healthy individuals using DTI and found that the APOE e4 allele affects WM integrity. In detail, we observed significantly reduced FA values in younger APOE e4-carriers and increased MD in older e4-carriers relative to matched non-carriers in widespread areas of the brain. Reduced FA values in APOE e4-carriers relative to non-carriers were also found when the data from both groups were combined. No significant interactions between AGE and GENOTYPE P-values refer to t-tests (parametric data) and w 2 -tests (categorical data).
Effect of APOE e4 allele on brain white matter integrity V Heise et al were observed, suggesting that APOE has an effect on WM that is evident even in early adulthood and remains relatively stable throughout adulthood. Increased MD and decreased FA are generally markers of pathology, thus our observation may provide clues to the basis of the vulnerability of APOE e4-carriers to late-life pathology.
Effect of APOE genotype on WM This is the first study to describe an effect of the APOE e4 allele on WM structure in a group of healthy young adults. Whole-brain analysis showed that young APOE e4-carriers had reduced FA values in widespread brain areas. Therefore, carrying the APOE e4 allele influences WM integrity even in young adulthood. A genotype effect on WM structure was also found in the older group. Although FA was not altered, widespread significant increases in MD were observed in APOE e4-carriers. This is in accordance with several other studies that reported effects of the APOE e4 allele on WM integrity in brain tracts, such as parahippocampal WM 38,53 and the corpus (c) significantly reduced FA (red) in APOE e4-carriers was found when data from both age group were pooled. (d) DR was significantly increased (yellow) in APOE e4-carriers when data from both age groups were pooled.
Effect of APOE e4 allele on brain white matter integrity V Heise et al callosum, 39, 54 whereas a recent study did not replicate these results. 55 Although the APOE genotype affects different measures of WM integrity in the two age groups, this is probably caused by age differences in FA and MD measures. It is possible that FA is more sensitive to detect differences in younger adults because we found that FA values decrease with age, independent of genotype. The opposite effect would be found for MD.
AD and amnesic MCI are associated with an increased volume of WM lesions compared with healthy controls, 56, 57 which predicts the rate of cognitive decline. 58 We did not find a significant effect of the APOE e4 allele and this is in concordance with two studies reporting an effect of APOE genotype on volume of WM lesions only for homozygous individuals and no gene-dose effect. 59, 60 Although APOE genotype effects were observed within WM regions in both the younger and the older group, we found that GM structure did not differ between APOE e4-carriers and non-carriers. This was interesting because we expected that at least in the older group the higher risk of AD for APOE e4-carriers would show in GM changes, especially in regions affected early by AD, 61 as was shown in two studies. 20, 53 However, other studies also failed to observe APOE-related structural GM differences in healthy subjects. [23] [24] [25] We, therefore, suggest that brain function [11] [12] [13] [14] [15] 52 and WM-related measurements are more sensitive than GM-related measurements to detect the physiological effects of carrying an APOE e4 allele.
Effect of age on WM integrity
As expected, we found age-related changes in FA and MD. FA was significantly lower in the older than in the younger group independent of APOE genotype. In addition, a widespread increase in MD was found in the older group. Several studies also observed reductions in FA with age mainly in prefrontal structures, [41] [42] [43] as well as changes in WM volume unevenly distributed across brain regions. 44 Therefore, our results are similar to age-related changes in WM integrity observed by other groups and our unbiased whole-brain approach strengthens these results.
Interpretation
The main goal of our study was to investigate whether differences in WM structure between APOE e4-carriers and non-carriers change across the lifespan. As TBSS revealed no significant AGE by GENOTYPE interactions for FA or MD we showed that genotypedependent differences in WM structure are already present in young adulthood and do not undergo significant differential changes with age. Previously, we have shown functional differences between APOE e4-carriers and non-carriers in the same group of younger subjects. 52 It is possible that WM differences might underlie these functional differences found in the default-mode network. Indeed, it has been shown that the structural connectivity between the cingulum, superior frontal occipital fasciculus and genu of the corpus callosum determine the functional links of the default-mode network. 62 We found that FA was significantly decreased in young APOE e4-carriers in the cingulum and genu Effect of APOE e4 allele on brain white matter integrity V Heise et al of the corpus callosum. However, the relationship between structural and functional differences between APOE e4-carriers and non-carriers require further investigation.
The effect of APOE on brain structure and function and the associated risk of AD remains poorly understood. The major role of apoE in the brain is the transport of lipid components that contribute to building up the myelin sheath. [30] [31] [32] In-vitro and in-vivo studies have shown that the apoE isoforms differentially modulate neuritic outgrowth, sprouting and branching [63] [64] [65] and the apoE4 isoform has been specifically associated with microtubule depolymerization 65 and axonal degeneration, 66 thus potentially affecting WM integrity. Although these studies point to a differential role for the apoE isoforms on WM structure, the molecular mechanisms require further investigation.
Limitations and future directions Our cross-sectional study did not cover the entire lifespan, but instead concentrated on distinct age groups of younger (20-35 years) and older (50-78 years) volunteers. The age-related changes in WM that we observed are unlikely to be caused by a cohort effect, but longitudinal studies would be required to rule this out. Given our observation of WM changes even in young adulthood, it would be particularly interesting to investigate differences in brain development of children and adolescents carrying the APOE e4 allele.
It is important to note that the changes in WM that we observe in APOE e4-carriers may not relate to AD risk because there are other genes in linkage disequilibrium with APOE e4 that might affect WM structure. 67 For example APOC1 and TOMM40 have been associated with increased risk of AD development 68 or earlier age of AD onset. 69 Large population samples would be needed to study the contribution of other genes to WM structure and AD. The link between APOE, WM structure and AD risk would be strengthened if evidence of a gene-dose effect in WM integrity that mirrored the gene-dose effect in AD risk could be found. WM changes might prove to be a useful imaging marker for early detection of subjects at increased risk of developing AD. The methods for including imaging markers in genome-wide association studies are now being worked out. 70 
Conclusion
This study demonstrated that individuals carrying the APOE e4 allelic variant have different WM-related measurements even at a young age, but show no differences in GM structure. No significant interactions of genotype and age group were found indicating that differences in WM structure between APOE e4-carriers and non-carriers remain relatively stable during adulthood. The WM changes we observed in young adults occur decades before any impending cognitive or clinical manifestations of disease, and are thus probably not caused by preclinical AD pathology. Nevertheless, the changes we see mirror those found in early AD and MCI and may, therefore, inform our understanding of the increased risk of disease in APOE e4-carriers.
